title: Chris Ashton talks about his career and the recent merger of Argenta Discovery and Etiologics. Interview by Steve Carney.
abstract: Chris Ashton describes the driving force behind the merger of Argenta Discovery and Etiologics, as well as detailing the highlights and strategies of the company's new drug discovery programme.
authors.forename: Chris
authors.initials: C
authors.lastname: Ashton
mesh_terms: D001709:Biotechnology; D015195:Drug Design; D004345:Drug Industry; D006801:Humans; D008297:Male; D017149:Private Sector; D012106:Research; D013678:Technology, Pharmaceutical